REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA
Clinical trials for REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for Hard-to-Treat lymphoma
Disease control OngoingThis study tests a new drug combination (ALX148, rituximab, and lenalidomide) in people with B-cell non-Hodgkin lymphoma that has not responded to prior treatment. The goal is to find the best dose and see if the combo can shrink or control the cancer. About 47 adults with variou…
Matched conditions: REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New combo aims to unmask cancer cells in Tough-to-Treat lymphoma
Disease control OngoingThis study is for adults with diffuse large B-cell lymphoma that has returned or stopped responding to standard treatments. The trial combines two drugs: one that helps the immune system see cancer cells (TTI-622) and another that boosts the immune attack (pembrolizumab). The goa…
Matched conditions: REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC